Haemonetics (HAE) Deferred Taxes (2015 - 2026)

Haemonetics has reported Deferred Taxes for 12 years, with the latest figure at $668000.0 in Q2 2026.

• On a quarterly basis, Deferred Taxes rose 120.67% year-over-year to $668000.0 in Q2 2026; TTM through Jun 2026 was -$22.6 million, a 391.02% decrease from a year earlier, with the FY2026 full-year figure at -$26.5 million, down 407.2% from the prior year.
• Deferred Taxes was $668000.0 for Q2 2026 at Haemonetics, up from -$20.5 million in the prior quarter.
• The five-year high for Deferred Taxes was $3.4 million in Q1 2025, with the low at -$20.5 million in Q1 2026.
• Average Deferred Taxes over 5 years is -$2.8 million, with a median of -$2.3 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Deferred Taxes surged 219.41% in 2022, then tumbled 706.19% in 2026.
• Over 5 years, Deferred Taxes stood at $3.0 million in 2022, then sank by 207.66% to -$3.2 million in 2023, then climbed by 25.52% to -$2.4 million in 2024, then climbed by 14.69% to -$2.1 million in 2025, then soared by 132.4% to $668000.0 in 2026.
• The last three Deferred Taxes figures came in at $668000.0 (Q2 2026), -$20.5 million (Q1 2026), and -$2.1 million (Q4 2025), per Business Quant data.